Tim Friede's Venom Immunity Sparks New Antivenom Research
Groundbreaking research into snakebite treatment using unique antibodies from Tim Friede reveals potential for broad-spectrum antivenom.
Subscribe to unlock this story
We really don't like cutting you off, but you've reached your monthly limit. At just $5/month, subscriptions are how we keep this project going. Start your free 7-day trial today!
Get Started
Glanville, who grew up in rural Guatemala, said he had long been aware of the health problems posed by snakebites and immediately recognized that Friede’s experience presented a unique opportunity.
Man who injected himself with venom hundreds of times could revolutionize snakebite treatment
CNN·1d·ReliableThis source consistently reports facts with minimal bias, demonstrating high-quality journalism and accuracy.Leans LeftThis outlet slightly leans left.
Friede’s journey has not been without its missteps.
Snakes have bitten this man hundreds of times. His blood could help make a better treatment
Boston Herald·1d·Mostly ReliableThis source is generally reliable but sometimes includes opinion, propaganda, or minor inaccuracies.Leans RightThis outlet slightly leans right.
While no doctor or emergency medical technician — or anyone, really — would ever suggest this is a remotely good idea, experts say his method tracks how the body works.
Snakes have bitten this man hundreds of times. His blood could help save lives.
NBC News·1d·ReliableThis source consistently reports facts with minimal bias, demonstrating high-quality journalism and accuracy.CenterThis outlet is balanced or reflects centrist views.
Snakebites are a neglected global health crisis, with the World Health Organization estimating over 2.7 million cases of envenoming and 100,000 deaths each year, mostly in rural and under-resourced regions.
A Universal Antivenom Is on the Horizon, Thanks to This Man Who Made Himself Immune to Snakebites
The Debrief·1d·Mixed ReliableThis source has a mixed track record—sometimes accurate but also prone to bias, sensationalism, or incomplete reporting.CenterThis outlet is balanced or reflects centrist views.
As astonishing and world-changing as it would be to have a single effective antivenom that could be kept everywhere refrigeration exists, the path to this point is possibly more amazing.
IFL Science·1d·Mostly ReliableThis source is generally reliable but sometimes includes opinion, propaganda, or minor inaccuracies.Leans LeftThis outlet slightly leans left.
The cocktail, which combines two protective antibodies from Friede’s blood and a small molecule venom inhibitor, opens a path towards a universal antivenom, according to research published in the journal Cell.
Snake collector’s immunity quest opens path towards universal antivenom
The Guardian·1d·ReliableThis source consistently reports facts with minimal bias, demonstrating high-quality journalism and accuracy.Leans LeftThis outlet slightly leans left.
Summary
After 18 years of self-immunization with venom, Tim Friede's antibodies have led researchers at Centivax to design a groundbreaking broad-spectrum antivenom. Studying Friede's blood, scientists identified two antibodies effective against venom from multiple snake species. Their experimental formula showed promise in mice, offering protection against 13 species and partial against others, but has yet to enter human trials. Despite its potential, experts caution more work is needed, particularly for snakes like vipers. Friede's unique journey, involving hundreds of snakebites, highlights a significant advancement in snakebite treatment amidst a global health crisis.
Perspectives
A new universal antivenom for snake bites has been developed using human antibodies from Tim Friede, who self-immunized with snake venom over 18 years. This research is viewed as a major breakthrough in snake bite treatment.
The current antivenom methods rely on animal-derived antibodies which can cause severe allergic reactions; the new development aims to eliminate these risks and improve accessibility and effectiveness in treating snakebites globally.
Field trials on dogs are planned, with hopes to transition to human trials, highlighting the urgency of addressing the global health crisis posed by snake bites, particularly in underserved areas.
FAQs
History
- 1d